MicroRNA Assisted Gene Regulation in Colorectal Cancer

Adewale O Fadaka1, Ashley Pretorius2, Ashwil Klein3

  • 1Department of Biotechnology, Faculty of Natural Sciences, University of the Western Cape, Private Bag X17, Bellville, 7535 Cape Town, South Africa. afadaka@uwc.ac.za.

Insights

This study identifies five microRNAs crucial for gene silencing in colorectal cancer (CRC). Computational analysis reveals their strong binding affinity, offering insights into molecular mechanisms for improved CRC diagnosis and treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Bioinformatics

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer mortality, with most cases diagnosed at advanced, metastatic stages.
  • Gene regulation by small non-coding RNAs, like microRNAs, is critical in cancer development and progression.
  • Understanding microRNA-mediated gene silencing mechanisms in CRC is essential for advancing diagnostics and therapeutics.

Purpose of the Study:

  • To predict the molecular mechanisms of gene regulation via microRNA-mRNA interactions in colorectal cancer.
  • To identify key microRNAs involved in the gene silencing pathways relevant to CRC.

Main Methods:

  • In silico identification of five candidate microRNAs targeting genes implicated in CRC.
  • Utilized databases (miRTarBase, gbCRC, CoReCG, DAVID) for target prediction, correlation, and prioritization.
  • Employed molecular docking (PATCHDOCK) and visualization tools (Schrödinger, Discovery Studio) to analyze microRNA-mRNA-protein interactions.

Main Results:

  • Five candidate microRNAs demonstrated significant binding affinity to their predicted mRNA targets.
  • Computational analysis confirmed the potential of these microRNAs to regulate gene expression through silencing mechanisms.
  • Molecular docking provided insights into the specific interactions between microRNAs, mRNA, and argonaute proteins.

Conclusions:

  • The identified microRNAs play a crucial role in the gene silencing mechanism within colorectal cancer.
  • This research elucidates microRNA-based gene regulation, paving the way for novel diagnostic and therapeutic strategies for CRC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K